ACTIVATION OF ONCOGENES IN HUMAN ORAL-CANCER CELLS - A NOVEL CODON-13 MUTATION OF C-H-RAS-1 AND CONCURRENT AMPLIFICATIONS OF C-ERBB-1 AND C-MYC

被引：1

作者：

TADOKORO, K

UEDA, M

OHSHIMA, T

FUJITA, K

RIKIMARU, K

TAKAHASHI, N

ENOMOTO, S

TSUCHIDA, N

机构：

[1] TOKYO MED & DENT UNIV,FAC DENT,DEPT ORAL MICROBIOL,BUNKYO KU,TOKYO 113,JAPAN

[2] TOKYO MED & DENT UNIV,FAC DENT,DEPT ORAL & MAXILLOFACIAL SURG 2,BUNKYO KU,TOKYO 113,JAPAN

来源：

ONCOGENE | 1989年 / 4卷 / 04期

关键词：

D O I：

暂无

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：499 / 505

页数：7

共 50 条

[31] Chronic iron exposure and c-Myc/H-ras-mediated transformation in fallopian tube cells alter the expression of EVI1 amplified at 3q26.2 in ovarian cancer
Rockfield, Stephanie
Kee, Younghoon
Nanjundan, Meera
ONCOGENESIS, 2019, 8 (9)
[32] Diminazene aceturate-induced cytotoxicity is associated with the deregulation of cell cycle signaling and downregulation of oncogenes Furin, c-MYC, and FOXM1 in human cervical carcinoma Hela cells
Gharbaran, Rajendra
Sayibou, Zouberou
Atamturktur, Seher
Ofosu-Mensah, Jeithy Jason
Soto, John
Boodhan, Nicholas
Kolya, Saaimah
Onwumere, Onyekwere
Chang, Lynne
Somenarain, Latchman
Redenti, Stephen
JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, 2024, 38 (01)
[33] Expression pattern of Notch intracellular domain (NICD) and Hes-1 in preneoplastic and neoplastic human oral squamous epithelium: their correlation with c-Myc, clinicopathological factors and prognosis in Oral cancer
Ravindran Gokulan
Devaraj Halagowder
Medical Oncology, 2014, 31
[34] Expression pattern of Notch intracellular domain (NICD) and Hes-1 in preneoplastic and neoplastic human oral squamous epithelium: their correlation with c-Myc, clinicopathological factors and prognosis in Oral cancer
Gokulan, Ravindran
Halagowder, Devaraj
MEDICAL ONCOLOGY, 2014, 31 (08)
[35] Suppression of RAD21 Induces Senescence of MDA-MB-231 Human Breast Cancer Cells Through RB1 Pathway Activation Via c-Myc Downregulation
Zhu, Shan
Zhao, Li
Li, Yueyang
Hou, Pingfu
Yao, Ruosi
Tan, Jiang
Liu, Dongxu
Han, Liping
Huang, Baiqu
Lu, Jun
Zhang, Yu
JOURNAL OF CELLULAR BIOCHEMISTRY, 2016, 117 (06) : 1359 - 1369
[36] CHARACTER OF STRUCTURE ALTERATIONS OF HRAS-1, C-MYC, ERBB-1 (HER-1), ERBB-2 (HER-2/NEU) ONCOGENES, RB-1, P53 ANTIONCOGENES AND CHROMOSOME-17 DELETIONS IN NON-SMALL-CELL HUMAN LUNG CARCINOMAS
IMYANITOV, EN
NIKIFOROVA, IF
CHERNITSA, OI
BABENKO, VI
SOKOLOV, SI
MAKSIMISHINA, MG
KNYAZEV, PG
EKSPERIMENTALNAYA ONKOLOGIYA, 1993, 15 (01): : 50 - 55
[37] LOW-FREQUENCY OF ALTERATIONS OF ERBB-1 (HER-1),ERBB-2 (HER-2/NEU), C-MYC, HRAS-1 ONCOGENES, RB-1, P53 ANTIONCOGENES AND DELETIONS OF SOME LOCI OF CHROMOSOME-17 IN HUMAN THYROID CARCINOMAS
IMYANITOV, EN
CHERNITSA, OI
NIKIFOROVA, IF
SOKOLOV, SI
VALDINA, EA
PLUTALOV, OV
BERLIN, YA
KNYAZEV, PG
EKSPERIMENTALNAYA ONKOLOGIYA, 1993, 15 (02): : 37 - 41
[38] A Novel BRD Family PROTAC Inhibitor dBET1 Exerts Great Anti-Cancer Effects by Targeting c-MYC in Acute Myeloid Leukemia Cells
Zhang, Kunlong
Gao, Li
Wang, Jianwei
Chu, Xinran
Zhang, Zimu
Zhang, Yongping
Fang, Fang
Tao, Yanfang
Li, Xiaolu
Tian, Yuanyuan
Li, Zhiheng
Sang, Xu
Ma, Li
Lu, Lihui
Chen, Yanling
Yu, Juanjuan
Zhuo, Ran
Wu, Shuiyan
Pan, Jian
Hu, Shaoyan
PATHOLOGY & ONCOLOGY RESEARCH, 2022, 28
[39] Dicer1e depletion promotes DNA damage and induces apoptosis in oral cancer cells via ERK, c-Myc, and p53-dependent mechanisms
Cantini, L. P.
Andino, L. M.
Jakymiw, A.
MOLECULAR BIOLOGY OF THE CELL, 2015, 26
[40] REDUCED INDUCTION OF C-FOS BUT NOT OF C-MYC EXPRESSIONS IN A NONTUMORIGENIC REVERTANT R1 OF EJ-RAS-TRANSFORMED NIH/3T3 CELLS TREATED WITH 12-O-TETRADECANOYLPHORBOL-13-ACETATE (TPA)
SUZUKI, H
FUJITA, H
OGISO, Y
ODA, A
KUZUMAKI, N
UCHINO, J
EXPERIMENTAL CELL RESEARCH, 1989, 184 (02) : 524 - 528

← 1 2 3 4 5 →